Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	18,744	11,703	10,129	8,835	10,576	10,702
Market Cap Growth	60.90%	15.54%	14.65%	-16.46%	-1.18%	-31.87%
Enterprise Value	35,691	28,630	28,889	30,129	34,797	36,069
PE Ratio	-	-20.93	-4.14	21.19	-2.65	-10.71
PS Ratio	1.17	0.74	0.68	0.56	0.64	0.63
PB Ratio	2.58	1.56	1.30	0.86	1.06	0.77
P/FCF Ratio	21.35	13.90	9.72	37.44	16.58	47.99
P/OCF Ratio	13.49	8.55	6.37	11.07	8.70	14.31
EV/Sales Ratio	2.23	1.81	1.94	1.90	2.09	2.14
EV/EBITDA Ratio	21.82	17.41	-35.45	9.99	-19.69	28.47
EV/EBIT Ratio	69.30	58.31	-13.61	17.87	-10.47	-79.27
EV/FCF Ratio	40.65	34.00	27.72	127.67	54.54	161.75
Debt / Equity Ratio	2.74	2.68	2.76	2.28	2.63	1.96
Debt / EBITDA Ratio	12.19	12.26	-26.46	7.78	-14.94	21.58
Debt / FCF Ratio	22.71	23.93	20.69	99.40	41.38	122.61
Quick Ratio	0.47	0.54	0.57	0.61	0.51	0.56
Current Ratio	0.89	1.02	1.05	1.14	0.99	0.99
Asset Turnover	0.37	0.37	0.33	0.33	0.32	0.29
Interest Coverage	0.49	0.46	-2.20	1.59	-3.99	-0.55
Return on Equity (ROE)	-6.90%	-7.60%	-28.00%	4.10%	-34.00%	-7.10%
Return on Assets (ROA)	-1.20%	-1.30%	-5.40%	0.90%	-7.60%	-1.70%
Return on Capital (ROIC)	0.79%	1.57%	-7.48%	3.38%	-9.80%	-1.07%
Earnings Yield	-2.63%	-4.78%	-24.15%	4.72%	-37.73%	-9.33%
FCF Yield	4.68%	7.19%	10.29%	2.67%	6.03%	2.08%
Buyback Yield / Dilution	-0.72%	-0.81%	-0.27%	-1.10%	-0.37%	-6.86%
Total Shareholder Return	-0.72%	-0.81%	-0.27%	-1.10%	-0.37%	-6.86%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).